Subsequent Dyslipidemia and Factors Associated with Mortality in Schizophrenia: A Population-Based Study in Taiwan
<i>Background:</i> Persons with schizophrenia are at greater risk of developing subsequent medical conditions. To date, few studies have examined comprehensively the risks, mortality and survival rates in schizophrenia and subsequent dyslipidemia over different time periods. The objectiv...
Main Authors: | Mei-Chi Hsu, Wen-Chen Ouyang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Healthcare |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9032/9/5/545 |
Similar Items
-
Use of Charlson Comorbidity Index and Nomogram to Predict Mortality in Elderly Patients with Late-Life Schizophrenia
by: Mei-Chi Hsu, et al.
Published: (2021-06-01) -
Pharmacological Interventions to Treat Antipsychotic-Induced Dyslipidemia in Schizophrenia Patients: A Systematic Review and Meta Analysis
by: Pruntha Kanagasundaram, et al.
Published: (2021-03-01) -
Risk for subsequent infection and mortality after hospitalization among patients with multidrug-resistant gram-negative bacteria colonization or infection
by: Wen-Pin Tseng, et al.
Published: (2018-07-01) -
Association Between ApoA1 Gene Polymorphisms and Antipsychotic Drug-Induced Dyslipidemia in Schizophrenia
by: Fan L, et al.
Published: (2021-04-01) -
Diabetes Mellitus and Dyslipidemia- A Detailed Analysis
by: Brijesh Mukherjee, et al.
Published: (2021-05-01)